has been cited by the following article(s):
|
[1]
|
Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: A single‐centre double‐blind randomised controlled trial
BJOG: An International Journal of Obstetrics & Gynaecology,
2023
DOI:10.1111/1471-0528.17445
|
|
|
|
|
[2]
|
Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials
American Journal of Obstetrics & Gynecology MFM,
2023
DOI:10.1016/j.ajogmf.2023.101049
|
|
|
|
|
[3]
|
Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients
BMC Pregnancy and Childbirth,
2023
DOI:10.1186/s12884-023-06100-8
|
|
|
|
|
[4]
|
Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials
American Journal of Obstetrics & Gynecology MFM,
2023
DOI:10.1016/j.ajogmf.2023.101049
|
|
|
|
|
[5]
|
Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2021.09.025
|
|
|
|
|
[6]
|
Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2021.09.025
|
|
|
|